Format
Sort by
Items per page

Send to

Choose Destination

Best matches for testosterone therapy for men:

Testosterone therapy for transgender men. Irwig MS et al. Lancet Diabetes Endocrinol. (2017)

[Testosterone replacement therapy for hypogonadism in men with prostate cancer]. Jensen CF et al. Ugeskr Laeger. (2017)

Testosterone Therapy in Men With Prostate Cancer. Kaplan AL et al. Eur Urol. (2016)

Search results

Items: 1 to 20 of 6417

1.

Testosterone replacement therapy is associated with an increased risk of urolithiasis.

McClintock TR, Valovska MI, Kwon NK, Cole AP, Jiang W, Kathrins MN, Bhojani N, Haleblian GE, Koehlmoos T, Haider AH, Basaria S, Trinh QD.

World J Urol. 2019 Mar 23. doi: 10.1007/s00345-019-02726-6. [Epub ahead of print]

PMID:
30903351
2.

Does sex hormone treatment reverse the sex-dependent stress regulation? A longitudinal study on hypothalamus-pituitary-adrenal (HPA) axis activity in transgender individuals.

Fuss J, Claro L, Ising M, Biedermann SV, Wiedemann K, Stalla GK, Briken P, Auer MK.

Psychoneuroendocrinology. 2019 Mar 14;104:228-237. doi: 10.1016/j.psyneuen.2019.02.023. [Epub ahead of print]

PMID:
30897530
3.

Association of Testosterone Replacement Therapy and the Incidence of a Composite of Postoperative In-Hospital Mortality and Cardiovascular Events in Men Undergoing Cardiac Surgery.

Argalious MY, Steib J, Daskalakis N, Mao G, Li M, Armanyous S, Roselli E.

Anesth Analg. 2019 Mar 14. doi: 10.1213/ANE.0000000000004115. [Epub ahead of print]

PMID:
30896595
4.

Aging and the Male Reproductive System.

Kaufman JM, Lapauw B, Mahmoud A, T'Sjoen G, Huhtaniemi IT.

Endocr Rev. 2019 Mar 19. pii: er.2018-00178. doi: 10.1210/er.2018-00178. [Epub ahead of print]

PMID:
30888401
5.

Fertility preservation options for transgender and gender-nonconforming individuals.

Moravek MB.

Curr Opin Obstet Gynecol. 2019 Feb 18. doi: 10.1097/GCO.0000000000000537. [Epub ahead of print]

PMID:
30870185
6.

The impact of genetic polymorphism on CYP19A1 in androgen-deprivation therapy among Japanese men.

Shiota M, Fujimoto N, Tsukahara S, Ushijima M, Takeuchi A, Kashiwagi E, Inokuchi J, Tatsugami K, Uchiumi T, Eto M.

Cancer Chemother Pharmacol. 2019 Mar 13. doi: 10.1007/s00280-019-03811-8. [Epub ahead of print]

PMID:
30868236
7.

Testosterone Therapy in Men With Hypogonadism Prevents Progression From Prediabetes to Type 2 Diabetes: Eight-Year Data From a Registry Study.

Yassin A, Haider A, Haider KS, Caliber M, Doros G, Saad F, Garvey WT.

Diabetes Care. 2019 Mar 12. pii: dc182388. doi: 10.2337/dc18-2388. [Epub ahead of print]

PMID:
30862651
8.

Late-onset Hypogonadism and Testosterone Therapy - A Summary of Guidelines from the American Urological Association and the European Association of Urology.

Fode M, Salonia A, Minhas S, Burnett AL, Shindel AW.

Eur Urol Focus. 2019 Mar 8. pii: S2405-4569(19)30056-2. doi: 10.1016/j.euf.2019.02.021. [Epub ahead of print]

PMID:
30858073
9.

Testosterone therapy may reduce prostate cancer risk due to testosterone deficiency at a young age via stabilizing serum testosterone levels.

Zhang X, Zhong Y, Saad F, Haider KS, Haider A, Clendenin AG, Xu X.

Aging Male. 2019 Mar 12:1-7. doi: 10.1080/13685538.2019.1578739. [Epub ahead of print]

PMID:
30857458
10.

Kallmann Syndrome.

Sonne J, Lopez-Ojeda W.

StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2019 Jan-.
2019 Feb 20.

11.

Testosterone replacement in congenital hypogonadotropic hypogonadism maintains bone density but has only limited osteoanabolic effects.

Antonio L, Caerels S, Jardi F, Delaunay E, Vanderschueren D.

Andrology. 2019 Mar 8. doi: 10.1111/andr.12604. [Epub ahead of print]

PMID:
30851011
12.

Erectile Dysfunction: An Umbrella Review of Meta-Analyses of Risk-Factors, Treatment, and Prevalence Outcomes.

Allen MS, Walter EE.

J Sex Med. 2019 Mar 1. pii: S1743-6095(19)30354-6. doi: 10.1016/j.jsxm.2019.01.314. [Epub ahead of print] Review.

PMID:
30833150
13.

Androgens Ameliorate Impaired Ischemia-Induced Neovascularization due to Aging in Male Mice.

Lam YT, Lecce L, Yuen SC, Wise SG, Handelsman DJ, Karas RH, Ng MKC.

Endocrinology. 2019 Mar 4. pii: en.2018-00951. doi: 10.1210/en.2018-00951. [Epub ahead of print]

PMID:
30830222
14.

CORRECTION OF ANDROGEN DEFICIENCY IN MEN WITH HYPOTHYROIDISM.

Krytskyy T, Pasyechko N.

Georgian Med News. 2019 Jan;(286):77-82.

PMID:
30829594
15.

The effects of testosterone replacement therapy on the prostate: a clinical perspective.

Miah S, Tharakan T, Gallagher KA, Shah TT, Winkler M, Jayasena CN, Ahmed HU, Minhas S.

F1000Res. 2019 Feb 25;8. pii: F1000 Faculty Rev-217. doi: 10.12688/f1000research.16497.1. eCollection 2019. Review.

16.

No correlation between serum testosterone levels and state-level anger intensity in transgender people: Results from the European Network for the Investigation of Gender Incongruence.

Defreyne J, Kreukels B, T'Sjoen G, Staphorsius A, Den Heijer M, Heylens G, Elaut E.

Horm Behav. 2019 Mar 2;110:29-39. doi: 10.1016/j.yhbeh.2019.02.016. [Epub ahead of print]

PMID:
30822410
17.

The My-T study: Patient satisfaction and preference comparing topical and nasal testosterone therapies.

Lee J, Brock G, Barkin J, Bryson N, Gronski MA, Ormsby R.

Can Urol Assoc J. 2019 Feb 26. doi: 10.5489/cuaj.5680. [Epub ahead of print]

PMID:
30817284
18.

Gonadal function and testicular histology in males with Prader-Willi syndrome.

Matsuyama S, Matsui F, Matsuoka K, Iijima M, Takeuchi M, Ida S, Matsumoto F, Mizokami A.

Endocrinol Diabetes Metab. 2018 Oct 30;2(1):e00049. doi: 10.1002/edm2.49. eCollection 2019 Jan.

19.

Assessment of Gender-Affirming Hormone Therapy Requirements.

Fernandez JD, Kendjorsky K, Narla A, Villasante-Tezanos AG, Tannock LR.

LGBT Health. 2019 Feb 27. doi: 10.1089/lgbt.2018.0116. [Epub ahead of print]

PMID:
30810452
20.

Metabolic Effects of Testosterone Therapy in Men with Type 2 Diabetes and Metabolic Syndrome.

Hackett G.

Sex Med Rev. 2019 Feb 22. pii: S2050-0521(18)30147-1. doi: 10.1016/j.sxmr.2018.12.004. [Epub ahead of print] Review.

PMID:
30803918

Supplemental Content

Loading ...
Support Center